Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study - Griffith, D E; Eagle, G; Thomson, R (2018)
(e-pub ahead of print). Doi: 10.1164/rccm.201807-1318OC